Management of coronary artery disease: therapeutic options in patients with diabetes (Q33996007)

30 July 2017

1 reference

title

Management of coronary artery disease: therapeutic options in patients with diabetes (English)

1 reference

30 July 2017

main subject

coronary artery disease

1 reference

T Hammoud

1

1 reference

30 July 2017

J F Tanguay

series ordinal

2

1 reference

30 July 2017

M G Bourassa

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Journal of the American College of Cardiology

30 July 2017

published in

1 reference

30 July 2017

volume

36

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

355-365

1 reference

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of diabetes mellitus on formation of coronary collateral vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Potential mechanisms promoting restenosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Platelet abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

In Vivo Platelet Activation in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Large Platelets Circulate in an Activated State in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin resistance: syndrome or tendency?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Is insulin really a heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin and risk of cardiovascular disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin resistance and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Comparison of secondary prevention measures after myocardial infarction in subjects with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Pharmacological treatment of diabetic patients with cardiovascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Use of Thrombolysis for Acute Myocardial Infarction in the Presence of Diabetic Retinopathy in the UK, and Associated Ocular Haemorrhagic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

GP IIb/IIIa antagonists. Clinical experience and potential uses in cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Beta-blockers and sudden cardiac death.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Diabetes mellitus and congestive heart failure. Further knowledge needed

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Procedural results and late clinical outcomes following multivessel coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Problem of angioplasty in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Will blocking the platelet save the diabetic?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900732-4

7 January 2021

10.1016/S0735-1097(00)00732-4

Identifiers

DOI

1 reference

30 July 2017

1 reference